Carlyle(US:CG) Prnewswire·2026-03-23 12:59Core Insights - Resonetics has successfully completed the acquisition of Resolution Medical, enhancing its capabilities in delivering integrated device solutions for interventional, structural heart, and neuromodulation markets [1][2]. Group 1: Acquisition Details - The acquisition expands Resonetics' design, finished device, and sub-assembly capabilities, supporting the full product lifecycle from concept to commercialization and scaled production [2]. - By integrating Resolution Medical's expertise in biosimulation, design, new product introduction, and cleanroom assembly with Resonetics' AGILE Product Development group, the company aims to streamline processes for OEMs, reducing complexity and improving execution [2]. Group 2: Strategic Importance - The acquisition is a significant milestone in Resonetics' growth strategy, as it allows the company to take greater ownership of development and manufacturing processes, particularly in high-growth areas like neuromodulation [3]. - The combination of both companies enhances Resonetics' ability to support innovative therapies, providing customers with more efficient program execution and increased confidence as devices move toward commercialization [3]. Group 3: Leadership Perspectives - Kevin Kelly, CEO of Resonetics, emphasized that the acquisition strengthens the company's capacity to execute integrated programs at scale [3]. - Peter Herman, CEO of Resolution Medical, noted that joining Resonetics will amplify their engineering capabilities by leveraging broader manufacturing depth and global resources [4]. Group 4: Company Background - Resonetics, founded in 1987, is a leader in advanced engineering and manufacturing solutions for the medical device industry, with a focus on laser processing, nitinol manufacturing, and photochemical machining [5]. - The company operates 18 facilities and employs over 3,000 associates across multiple countries, backed by private equity firms Carlyle and GTCR [5].